- Moxie is a clinical-grade operating system designed for independent aesthetic practices, providing essential operational infrastructure and compliance solutions in a rapidly growing $18 billion U.S. medical aesthetics market.
- In March 2026, Moxie raised $25 million in a Series C funding round led by Viewpoint Ventures, bringing its total funding to $51 million, and launched its new product, Scale Suite, which offers multi-provider operational infrastructure and AI-driven compliance alerts.
- Moxie has worked with over 700 aesthetic practices, from solo injectors to multi-provider operations, helping them achieve structured workflows and financial clarity.
- The ideal buyer for Moxie's solutions is independent aesthetic practice owners who struggle with operational management and compliance, as Moxie's offerings address the gap in clinical standards and operational efficiency in the booming aesthetic medicine sector.
Moxie operates with a diverse departmental structure, comprising 16 distinct departments. The largest departments include Operations with 78 employees, Sales with 55, and Executive with 49. This distribution indicates a strong emphasis on operational efficiency and sales capabilities, which are critical for driving growth in the software development sector. Additionally, the presence of other departments such as Information Technology and Marketing further supports a well-rounded functional balance within the organization.
Moxie's workforce is geographically distributed across 32 locations, with a significant concentration in Atlanta, GA, which houses 99 employees. Other notable locations include New York, NY, with 11 employees, and San Bruno, CA, with 8. The 'Other' category accounts for a substantial portion of the workforce, indicating a remote or distributed work model that allows for flexibility and access to a broader talent pool. This geographic distribution highlights Moxie's adaptability in leveraging diverse locations to meet operational needs.
